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Abstract
Introduction—Nasoalveolar molding (NAM) is a treatment option available for early cleft care.
Despite the growing debate about NAM’s efficacy, questions remain regarding its prevalence and
demographic characteristics of families undergoing this technique prior to traditional cleft surgery.
Objectives—To determine the number of teams currently offering NAM, and to identify salient
clinical and sociodemographic variables in infants and families who choose NAM compared with
those who choose traditional cleft care across three well-established cleft centers.
Results—89% of US cleft teams contacted using phone surveys reveal that NAM is available at
39% of these centers. Chart reviews and phone correspondence with caregivers indicate that the
average distance to the cleft center was 65.5 miles and caregiver age averaged 30.9 (SD=5.7)
years. 85% of families who chose NAM received total or partial insurance coverage. No difference
in caregiver education, income, or distance to the clinic between treatment groups was found. On
average, infants receiving NAM and cleft surgery had larger clefts and had more clinic visits than
infants receiving traditional cleft surgery. Infants who were first-born and those who did not have
other siblings were more likely to receive NAM than infants who were residing with other
siblings.
Conclusions—Currently over one-third of US cleft centers offer NAM. While the cleft size was
larger in the NAM group, no treatment group differences in education, income, and distance to the
clinic were found.
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According to a recent CDC report, cleft lip and palate (CLP) is the second most common
birth defect (Canfield et al., 2006). Traditional cleft habilitation involves a lengthy process
of evaluations and treatment by a multidisciplinary team of specialists. Clefts of the primary
and secondary palate are repaired by about one year of age. The subsequent number of
surgical interventions for individuals can vary from 2 or 3 to as many as 20 surgeries before
the affected individual reaches early adulthood. Not surprisingly, treatment for CLP is
costly. The medical costs of interventions average $15,000 each, and the cost of habilitation
can average over $100,000 per individual (Snowden et al., 2003). This figure does not
measure other impacts such as psychosocial sequelae (e.g., multiple doctor visits by patients
and their caregivers, lost wages, etc.). Given current concerns regarding health costs and/or
affordability in the US, it is vital to examine healthcare access as well as the benefits and
disadvantages for families receiving cleft treatment protocols, like nasoalveolar molding
(NAM), that are intended to reduce treatment costs.
Over the past decade, NAM, a relatively new technique, has emerged in cleft care. NAM is
an early, pre-surgical intervention intended to reduce the severity of initial cleft deformity
through the use of surgical tape, an intraoral molding plate, and nasal stents. Typically,
NAM is initiated on newborns at approximately 1–2 months of age and is completed prior to
the closure of the primary palate (lip) at approximately 5 months of age. The infants must
undergo this treatment for about 3 months (unilateral cleft) or 5 months (bilateral cleft).
During this time, caregivers make daily adjustments to the tape on the infant’s face, as well
as attend weekly clinic appointments with the infant. Both short (4 months-1 year) and long-
term (4.5–9 years) studies indicate that NAM significantly improves nasal symmetry over
surgery alone (Maull et al., 1999; Ezzat et al., 2007; Jaeger et al., 2007; Barillas et al.,
2009). More specifically, NAM lengthens and widens the columella in bilateral clefts and
improves nostril height and width in a pre-surgical phase of treatment (Pai et al., 2005; Lee
et al., 2008; Nakamura et al., 2009; Chang et al., 2010).
However, the use of NAM is controversial, has polarized professionals in the field of
craniofacial habilitation, and has challenged the established ACPA standards of care.
According to NAM proponents, NAM reduces the severity of the cleft (e.g., nasal defect,
cleft size) and thereby improves future surgical results, reduces the need for other surgeries
like lip and nose revisions, and minimizes scarring. On the other hand, Berkowitz (2009)
argues that NAM + GPP (gingivoperiosteoplasty) compromises future facial growth.
Opponents also suggest that NAM places an extra emotional burden on the family system,
which already must adapt to having a newborn with a birth defect. In other words, the
described morphological benefits of NAM are not sufficient to counterbalance the burden
imposed on caregivers. Although NAM may be offered at a growing number of cleft centers,
it remains unclear how many centers actually provide NAM services and the potential
burden of care NAM places on caregivers/families. This paucity of data poses a serious
challenge to cleft care considering the pivotal role caregivers play in the treatment process.
For example, NAM caregivers are responsible for: 1) attending weekly clinic visits for
molding plate adjustments; 2) the daily care associated with cleaning and maintaining the
appliance; and 3) the proper positioning and adherence of the surgical tape that holds the
appliance in place. Infants with unilateral cleft lip require an average of 13–14 office visits,
while infants with bilateral cleft lip require 20–22 visits, which can cost caregivers a
significant amount of time and money. Some patients and their caregivers, for example,
travel hours to craniofacial centers for appointments and all patients and their caregivers
spend extended periods of time in waiting rooms (Levy-Bercowski et al., 2009). NAM
opponents assert that NAM places an extra emotional burden on the family system since
caregivers are already experiencing a critical period of adaptation to the arrival of a newborn
with a birth defect (Bradbury and Hewison, 1994; Pope et al., 2005).
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During this era of evidence-based outcomes, much attention in medicine has been given to
new treatment advances in terms of technology, techniques, and medications. The focus of
craniofacial habilitation transcends survival alone. Craniofacial teams typically focus on
treatment that promotes thriving—treatment designed to enhance appearance, speech, and
other factors associated with quality of life (QoL) (Broder and Wilson-Genderson, 2007).
Recent health models suggest that in addition to patients’ medical characteristics or status,
treatment outcomes may be influenced by contextual and environmental factors which may
be independent of clinical variables (e.g., width of the cleft) (Sischo and Broder, 2011).
Further, clinical decision-making and outcomes such as QoL and satisfaction with care are
often mediated by psychosocial factors. In pediatric health psychology, there is a robust
literature that recognizes that demographic, contextual, and psychosocial factors impact
decision-making, adherence, treatment effects, and QoL (Mellins et al., 2004; Patenaude and
Kupst, 2005; Patrick et al., 2007).
As cleft care strives to optimize treatment outcomes, such data can take a long time to
thoroughly evaluate and validate. To date, only one study has addressed the underlying
assumption of NAM treatment—that the benefits of the treatment to the child in saved
surgical costs outweigh other costs (Pfeifer et al., 2002). From a pragmatic perspective,
treatment access and utilization are important issues at a time when health costs are one of
the major political issues facing the US (DHHS, 2000).
In short, it is important to determine whether sociodemographic variables (e.g., income,
proximity to clinic, caregiver education) are associated with early treatment decisions
among caregivers having infants with cleft. It may be that birth order, education level, and
income are predictive of treatment choice rather than variables like age of caregiver, number
of caregivers in the home and/or proximity to the clinic. Such information may dispel or
confirm biases associated with the type of patients/families who choose NAM. Our study
will be the first to examine the prevalence of NAM across cleft teams and sociodemographic
and clinical variables associated with early cleft care at three established cleft centers in the
US. We expected that there would be systematic differences between the NAM and non-
NAM groups across diverse variables (e.g., distance from clinic, payer status, size of cleft).
The purposes of this study were:
1. To identify the number of cleft teams that offer NAM to infants.
2. To examine health care utilization, access to care, and enabling resources in
families whose infants with CLP undergo NAM compared to families whose
infants with CLP do not undergo NAM.
METHODS
To carry out our first goal, a phone survey was completed by investigators from one of the
study sites to ascertain the proportion of ACPA-sanctioned centers that offer NAM. One of
the authors systematically called US centers listed in the recent ACPA directory as having
evaluated more than 25 new patients annually. Descriptive statistics were used to identify
the number of centers that do or do not offer NAM.
A review of the literature on decision-making and health utilization/access and early cleft
care yielded a list of variables relevant for our chart review. To ascertain the relevant
information (e.g., income, caregiver education), investigators from each site were required
to contact the caregivers. We expected that there would be systematic differences between
the NAM and non-NAM groups across diverse variables (e.g., distance from clinic, payer
status, size of cleft). To obtain information about early cleft care, investigators from three
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well-established US cleft centers secured IRB approval (as this was a chart review, informed
consent was not required). One center (Site 1) is located in a northeastern urban area and is a
long-established site offering NAM. The other two renowned centers (Sites 2 and 3) are
located in rural areas in the southeast—one is a private hospital and the other is state-owned.
These two centers have introduced NAM within the past 24–30 months. At each center, one
or two members of the cleft team were responsible for identifying consecutive cases over the
past 18 months who have had NAM plus cleft surgery and those families whose infants had
traditional care only. Inclusion criteria included all infants with non-syndromic unilateral or
bilateral cleft who were consecutively evaluated at the three treatment sites within an 18-
month period.
The data first were analyzed for descriptive purposes without regard to site or NAM status.
Analyses were then performed to compare the sites without regard to NAM grouping status.
Lastly, analyses were completed comparing the NAM and non-NAM infants without regard
to site. Based on the distributions of data in the univariate analyses and the relatively small
sample size compared to the number of groups formed, it was not appropriate to analyze by
site and NAM status simultaneously (i.e., two-way analysis). Comparison of categorical
variables was completed using cross tabulation and Fisher’s Exact test. Comparison of
numeric variables was done by t-test for the two NAM groups or by one-way ANOVA with
Tukey’s HSD post hoc comparison for site groups. Bivariate statistics (Chi-square/Fisher’s
Exact for nominal or Unpaired t-tests for continuous variables) were used to evaluate
distributional differences between those families whose infants received NAM and cleft
surgery and those families whose infants underwent traditional care only.
RESULTS
Teams Offering NAM
Of the 207 US teams listed in the 2007–2008 ACPA Membership Team Directory, 132
teams (64%) met our inclusion criteria of treating more than 25 new patients annually. Of
these 132 teams that were contacted, 117 teams (89%) were reachable. The remaining 15
teams were unreachable (i.e. voice-mail, staff on disability or maternity leave, closed due to
inclement weather conditions, or non-working numbers). Of the 117 teams contacted, 43
teams (37%) reported that they offered NAM, and 74 teams reported that they did not offer
NAM. This result far exceeds estimates of 10–15% as expressed by the Americleft
Chairperson (Long, 2010).
Infants/Families Across Sites
A total of 83 families had infants who completed treatment at one of the three cleft centers
—Site 1 (n=36), Site 2 (n=19), and Site 3 (n=28). Over an 18 month study period
(September 2009–January 2010), 39 infants received a NAM device (47%) and cleft
surgery; while 44 (53%) infants underwent traditional care (cleft surgery only).
Table 1 presents the description of the families across the three centers that underwent cleft
care during the study period regardless of treatment group. Across the three sites, caregivers
were on average young (M=30.9 years old). Caregivers from Site 1 (northern/urban) were
significantly older on average (33.6 years) than the caregivers from the other two sites (28.9
years and 28.8 years), respectively. No differences across sites were found on the number of
clinic visits or the distance (averaged 65.5 miles) from the clinic. The caregiver education
and income level were also higher at Site 1 than the other two southern rural sites (p<0.01).
Approximately 26 of the 36 caregivers (72.2%) from the northern/urban site at least
completed college compared to 5 of 19 (26.3%) and 12 of 28 (42.9%) from Sites 2 and 3,
respectively. However, it is noted that a range of income and education levels were observed
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across sites. For example, twenty-eight percent of the families had an income of less than
$25,000/year, while 33% earned more than $100,000/year. Caregivers were mostly female
(n=79, 95%) and the majority of infants had two caregivers in the home (66%) with the
primary caregiver being predominantly non-Hispanic white (71%). With regards to private
insurance and Medicaid, one of the southern sites had significantly less private insurance
with 8 of 19 (42.1%) and higher proportion covered by Medicaid (63.2%) compared to the
other two sites which reported 51 of 64 (79.7%) with private insurance and 16 of 64 (25%)
with Medicaid. The majority of infants studied had unilateral clefts (n=62, 74.7%). Of those
infants who received NAM, 64% were fully covered by insurance, 21% (n=8) were partially
covered, and 15% (n=6) were not covered at all by third party payers. Thus, treatment was
partially or fully covered by insurance in 85% of the infants.
NAM and Non-NAM Comparisons
Table 2 compares the families whose infants received NAM and cleft surgery with those
who had traditional cleft care only. The number of clinic visits for patients receiving NAM
(M=14) was significantly higher than the number of clinic visits for non-NAM subjects
(M=3.14) (p<0.01) across the three sites. The size of the cleft for infants with unilateral cleft
who received NAM averaged 9.0 mm, which was significantly larger than the average cleft
size of 4.0 mm for infants undergoing traditional care only (p<0.01). The average size of the
bilateral clefts (combining the left and right sides) was 13.9 for the NAM group and 8.8 for
the non-NAM group. While the direction was larger for the NAM group, significance was
not obtained.
The majority of the infants are first or second born (n=61/83, 73%). However, there is a
significant difference by birth order—if the infant with cleft is first or second in the birth
order, they are more likely to have NAM. Conversely, caregivers residing in households
having other children more often choose traditional care for their infants (p<0.05).
No other differences in sociodemographic variables were found between treatment groups—
including distance to the clinic, income and Medicaid status. Furthermore, no statistical
difference between treatment groups was found regarding the number of caregivers residing
at home. With regards to ethnicity, there was no statistical difference between treatment
groups. However, a possible trend was observed at the p<0.08 level with African Americans
and Latinos more often receiving traditional care. However, due to the small numbers, this
trend is only speculative. In summary, given the nature of NAM, it is not surprising to find
differences in the number of visits to the clinic. However, the absence of difference based on
distance, income, and type of payer is noteworthy.
DISCUSSION
The results from the chart reviews revealed some interesting information regarding
sociodemographic comparisons between the two treatment groups. Both cleft size and the
number of clinic visits were significantly larger in the NAM group than non-NAM group.
Given the goals of NAM, it is logical that the extent of the defect may in part determine
treatment choice, both in terms of the teams’ recommendations and/or caregivers’ responses
to the size of the cleft. Surprisingly, distance from clinic, caregiver age, and income were
not associated with treatment choice. However, the infant birth order and the presence of
other children in the family were associated with treatment group. In short, multiple children
in the family and having the affected child not be first in the birth order are linked to having
traditional care. Such issues may relate to social support. Contextual factors, like quality of
the support system, have been found to affect treatment adherence, health care utilization,
and quality of life issues in families with chronic conditions (Horwitz et al., 1985;
Wallander and Varni, 1989; Drotar, 1997; Janicke et al., 2001). However, the data collected
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in this study merely capture size, not quality, of the family system. Another study limitation
is the lack of diverse ethnic representation in the sample. Despite a slight directional
tendency for African Americans and Latinos to select traditional care, it remains unclear and
merely speculative whether elective treatment or service utilization is linked to ethnicity, a
factor often associated with access to care (DHHS, 2000). Since a potential relationship
between ethnicity and socioeconomic status may also exist (Butani et al., 2008), further
investigation is needed in this area.
A follow-up study to determine the number of subsequent procedures completed over time
at individual sites across treatment groups may be revealing. In addition, it would be helpful
to know if the number of elective procedures is decreasing as a result of the economy,
unemployment rates, and/or the costs of care. On the other hand, the number of infants
receiving NAM may be increasing in response to increased insurance coverage of NAM and
prevalence of centers offering such care. Another way to ascertain prevalence and frequency
of NAM at centers is to include this information in the ACPA directories under team
services. Such a change would be congruent with the 2009 alteration to the ACPA’s
Parameters of Care that now includes infant orthopedics like NAM (ACPA, 1993).
Based on anecdotal information from the site directors, caregivers are informed about NAM
prior to their initial discussions with the plastic surgeons at the participating sites. Cleftline,
a toll-free service as well as a website through the Cleft Palate Foundation, is one such
mechanism that has enabled caregivers to become aware of NAM therapy through its
information about clefts and craniofacial care. Although we were unable to ascertain specific
hits for NAM information, it is clear that Cleftline is a well-utilized service for caregivers
and health providers, as it averaged 19,522 daily hits in 2010 (Gregson, 2011). Additionally,
those active on Cleftline can recount numerous discussions from parents and professionals
regarding NAM. While we were able to detect treatment group differences regarding
specific variables, a prospective study to replicate these findings is recommended. It may be
important to obtain a larger sample to examine differences across groups, as well as expand
the scope of information. For example, measuring stress, coping, and quality of the support
system may reveal significant issues associated with treatment choice. Further, we need
longitudinal studies to look at satisfaction with early cleft care over time. Although we may
not be able to definitely state whether there are fewer surgeries in the NAM group,
systematic collection of prospective data is imperative to evaluate those outcomes over time.
Data examining contextual and psychosocial factors are suggested to determine if time-
intensive therapies, like NAM, are detrimental to family cohesion and, if so, whether adjunct
support services are indicated. Conversely, it is possible that such substantial caregiver
involvement may empower parents, thereby increasing and strengthening family bonding.
Both qualitative and quantitative analyses are recommended to address such issues (Strauss
and Broder, 1991; Nelson, 2009).
In short, focusing on clinical factors alone is a limited approach to analyzing decision-
making. Long-term outcomes and satisfaction with treatment are multidimensional and often
mediated by multiple factors (Evers et al., 2003; Ganzini et al., 2003; Brod et al., 2007).
Thus, congruent with current health models (Sischo and Broder, 2011), use of multilevel and
multivariate analyses in a prospective study is recommended to increase our understanding
of decision-making and responses to early cleft care.
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TABLE 1
Descriptive Data Across Sites
Variable n (%) (N=83)
Gender of Primary Caregiver
 Female 79 (95.2)
 Male 4 (4.8)
Race/Ethnicity of Caregiver
 Non-Hispanic White 59 (71.1)
 Non-Hispanic Black 8 (9.6)
 Hispanic 5 (6)
 Asian 8 (9.6)
 Other 3 (3.6)
Education of Caregiver**
 <High School 5 (6)
 High School Diploma 23 (27.7)
 Some College 12 (14.5)
 College Degree 24 (28.9)
 Some Graduate School 2 (2.4)
 Professional/Graduate Degree 17 (20.5)
Family Income**
 0–25,000 23 (27.7)
 26,000–50,000 20 (24.1)
 51,000–100,000 13(15.7)
 >100,000 27 (32.5)
Other Children
 0 31 (37.3)
 1 26 (31.3)
 2 or more 26 (31.3)
Birth Order of Affected Child
 1st 33 (39.8)
 2nd 28 (33.7)
 3rd or more 22 (26.5)
Private Insurance**
 Yes 59 (71.1)
 No 24 (28.9)
Medicaid**
 Yes 28 (33.7)
 No 55 (66.3)
Was NAM Covered (N=39)
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Variable n (%) (N=83)
 Yes 25 (64.1)
 Partially 8 (20.5)
 No 6 (15.4)
Type of Cleft
 Bilateral 21 (25.3)
 Unilateral 62 (74.7)
Age of Caregiver (YRS)**
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TABLE 2
Descriptive Data Across Treatment Groups
Variable NAM (N=39) NON-NAM (N=44)
n (%)1 n (%)1
Gender of Primary Caregiver
 Female 39 (49.4) 40 (50.6)
 Male 0 (0) 4 (100)
Number of Caregivers in the Home
 1 5 (45.5) 6 (54.6)
 2 28 (50.9) 27 (49.1)
 3+ 6 (35.3) 11 (64.7)
Race/Ethnicity of Caregiver
 Non-Hispanic White 31 (52.5) 28 (47.5)
 Non-Hispanic Black 1 (12.5) 7 (87.5)
 Hispanic 2 (40) 3 (60)
 Asian 5 (62.5) 3 (37.5)
 Other 0 (0) 3 (100)
Education of Caregiver
 <High School 3 (60) 2 (40)
 High School Diploma 11 (47.8) 12 (52.2)
 Some College 3 (25) 9 (75)
 College Degree 12 (50) 12 (50)
 Some Graduate School 2 (100) 0 (0)
 Professional/Graduate Degree 8 (47.1) 9 (52.9)
Family Income
 0–25,000 10 (43.5) 13 (56.5)
 26,000–50,000 9 (45) 11 (55)
 51,000–75,000 6 (46.2) 7 (53.8)
 >100,000 14 (51.9) 13 (48.2)
Other Children*
 0 19 (61.3) 12 (38.7)
 1 11 (42.3) 15 (57.7)
 2 or more 9 (34.6) 17 (65.4)
Birth Order of Affected Child*
 1st 19 (57.6) 14 (42.4)
 2nd 15 (53.6) 13 (46.4)
 3rd or more 5 (22.7) 17 (77.3)
Private Insurance
 Yes 28 (47.5) 31 (52.5)
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Variable NAM (N=39) NON-NAM (N=44)
n (%)1 n (%)1
 No 11 (45.8) 13 (54.2)
Medicaid
 Yes 12 (42.9) 16 (57.1)
 No 27 (49.1) 28 (50.9)
Type of Cleft
 Bilateral 9 (42.9) 12 (57.1)
 Unilateral 30 (48.4) 32 (51.6)
Size of Cleft (MM) M(SD) M(SD)
 Bilateral Cleft (Lft + Rt Combined Average) (SD) 13.9 (5.3) 8.8 (6)
 Unilateral Average (SD)** 9.0 (5.5) 4 (4.3)
Number of Clinic Visits**
 M (SD) 14 (5.3) 3.14 (1.7)
Distance From Clinic (MI)
 M (SD) 77.7 (198.9) 54.6 (46.2)
Age of Caregiver (YRS)
 M (SD) 31.0 (5.8) 30.9 (5.8)
1
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